Literature DB >> 25588082

Serum endocan levels are correlated with the presence and severity of coronary artery disease in patients with hypertension.

Xiang-sheng Wang1, Wen Yang, Tong Luo, Jian-ming Wang, Yan-yan Jing.   

Abstract

BACKGROUND: Endothelial dysfunction is one of the most important early indicators of atherosclerosis in hypertension (HT) patients. Endocan has been reported to play a role in the pathophysiology of endothelial dysfunction.
OBJECTIVE: We sought to assess whether serum endocan levels are correlated with the presence and severity of coronary artery disease (CAD) in patients with HT.
METHODS: We measured endocan levels in 164 patients with HT and in 55 controls. The severity of CAD was assessed by the coronary atherosclerosis index scores.
RESULTS: Serum endocan levels were independently correlated with the presence and severity of CAD in HT patients.
CONCLUSION: Endocan might function as a useful biomarker for monitoring the development and progression of CAD in HT patients.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25588082     DOI: 10.1089/gtmb.2014.0274

Source DB:  PubMed          Journal:  Genet Test Mol Biomarkers        ISSN: 1945-0257


  15 in total

1.  Significance of serum endothelial cell specific molecule-1 (Endocan) level in patients with erectile dysfunction: a pilot study.

Authors:  M Karabakan; A Bozkurt; S Akdemir; M Gunay; E Keskin
Journal:  Int J Impot Res       Date:  2017-04-20       Impact factor: 2.896

2.  Effect of CPAP on New Endothelial Dysfunction Marker, Endocan, in People With Obstructive Sleep Apnea.

Authors:  Nejat Altintas; Levent Cem Mutlu; Dursun Cayan Akkoyun; Murat Aydin; Bulent Bilir; Ahsen Yilmaz; Atul Malhotra
Journal:  Angiology       Date:  2015-06-15       Impact factor: 3.619

3.  The relationship between serum endocan levels and the presence/severity of isolated coronary artery ectasia.

Authors:  Murat Gök; Harun Kundi; Emrullah Kiziltunç; Canan Topçuoğlu; Ender Örnek
Journal:  Cardiovasc Endocrinol Metab       Date:  2018-05-16

4.  The relationship of serum endocan levels and anti-TNF-alpha therapy in patients with ankylosing spondylitis.

Authors:  Fatma Zehra Kadayıfçı; Makbule Gezmen Karadağ
Journal:  Eur J Rheumatol       Date:  2018-03

5.  Is endocan a biochemical marker for asymptomatic target organ damage in hypertensive patients?

Authors:  Mustafa Tarık Ağaç; Behlül Kahyaoğlu; Muhammed Murat Necati Aksoy; Fatma Behice Cinemre; Mehmet Bülent Vatan; Yasemin Gündüz
Journal:  Anatol J Cardiol       Date:  2019-02       Impact factor: 1.596

6.  The higher serum endocan levels may be a risk factor for the onset of cardiovascular disease: A meta-analysis.

Authors:  Tianming Zhao; Yao Kecheng; Xuelei Zhao; Xuehua Hu; Jing Zhu; Yingnan Wang; Jixiang Ni
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

7.  Serum endocan levels in women with restless legs syndrome.

Authors:  Kenan Celik; Mehmet A Cikrikcioglu; Gulistan Halac; Elif Kilic; Siddika Ayhan; Nihal Ozaras; Kemal Yildiz; Rabia S Yildiz; Mehmet Zorlu; Cumali Karatoprak; Mustafa Cakirca; Muharrem Kiskac
Journal:  Neuropsychiatr Dis Treat       Date:  2015-11-19       Impact factor: 2.570

8.  Endocan and Non-Dipping Circadian Pattern in Newly Diagnosed Essential Hypertension.

Authors:  Tolga Çimen; Murat Bilgin; Ahmet Akyel; Mehmet Ali Felekoğlu; Ali Nallbani; Şeyda Özdemir; Gönül Erden; Alpaslan Öztürk; Mehmet Doğan; Ekrem Yeter
Journal:  Korean Circ J       Date:  2016-11-01       Impact factor: 3.243

9.  Plasma endocan level and prognosis of immunoglobulin A nephropathy.

Authors:  Yu Ho Lee; Jin Sug Kim; Se-Yun Kim; Yang Gyun Kim; Ju-Young Moon; Kyung-Hwan Jeong; Tae Won Lee; Chun-Gyoo Ihm; Sang-Ho Lee
Journal:  Kidney Res Clin Pract       Date:  2016-07-14

10.  Endocan Measurement for Active Behçet Disease.

Authors:  Ayhan Kul; Orhan Ateş; Meltem Alkan Melikoğlu; Mahir Uğur; Nurinnisa Öztürk; Gülsüm Erkayhan; İbrahim Koçer
Journal:  Arch Rheumatol       Date:  2017-03-24       Impact factor: 1.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.